Jefferies Upgrades AdaptHealth to Buy, Raises Price Target to $13
Benzinga Newsdesk 3 months ago
NewsUpgradesAnalyst RatingsPrice Target
Jefferies analyst Brian Tanquilut upgrades AdaptHealth (NASDAQ:AHCO) from Hold to Buy and raises the price target from $11 to $13.
Jefferies analyst Brian Tanquilut upgrades AdaptHealth (NASDAQ:AHCO) from Hold to Buy and raises the price target from $11 to $13.